Key message: Clinical manifestations of these lesions are extremely challenging. Experience in diagnosis and management of these lesions by most clinicians is limited. Therefore, additional diagnostic criterion that is simple and reliable and can be readily used to differentiate VMs
Dear Sir, Third molar popularly called as wisdom tooth has been a prime concern for oral and maxillofacial surgeons owing to its associated problems. The failure to erupt in oral cavity, because of mechanical obstruction leads to impaction (fusion) of tooth with jaw bone. Conservative care of the impacted tooth is not feasible, considering its unfavourable anatomy. Thus surgical removal of tooth remains the gold standard for impacted teeth. Furthermore, a host of factors such as occurrence of pericoronitis (localised infection surrounding wisdom tooth), secondary caries and debris lodgement complicate the scenario thereby requiring prompt service. Irrespective of the strict protocols undertaken, post-operative complications (alveolar osteitis and wound infection) have been reported in candidates.1 In order to control the wound infection, oral clinicians have been pushed to administer antibiotic via oral or intravenous route. Literature contains ample evidence on the former mode of delivery with an unclear summary. Meanwhile, neither a controversy prevails nor do valid documents exist on intravenous antibiotics. Less has been discussed on the impact of IV antibiotics in dental tributaries. This could be the possible reason for being unpopular among oral physicians. Current letter addresses the indications of IV antibiotics during third molar surgery to restore its unsupported preference. In emergency circumstances (critical illness), oral delivery is restricted and demand prompt service for patients with severe infections. The potential alternative for oral route in such crisis is IV antibiotics. Indications of IV antibiotics are more applicable to immune compromised patients considering their increased risk to bacteremia. Oral intake is mutually affected because of ill-health and preference of IV route serves the purpose. At the same time, antibiotic prescription should be at reserve for high-risk candidates which include indwelling central venous catheter, prosthetic joint and compromised health.2-5 Earlier researches have preferred Penicillin (1g IV/ 1 hr pre-op), Clindamycin (300 mg IV/ 1 hr pre-op) and Metronidazole (1g IV/ 1 hr pre-op) in the clinical trials.1 Former historical drug is popular among health care professionals because of improved performance over the Streptococci and long halflife. Candidates allergic to Penicillin could benefit from Clindamycin which is equally effective against anaerobes and Streptococci. The concentrations of Clindamycin reach peak level in tissue, thus enabling it to be indicated before minor oral surgical procedures. 6 Metronidazole's impelling resistance against the anaerobes responsible for majority of odontogenic infection enrol it among the standard IV drugs. Unique feature of IV antibiotic being quick absorption helps to attain peak level in surgical site immediately after the onset of injection. Hence forth, maintaining its potency throughout the surgical manoeuvre. A vital concern during their delivery is dosage timing which indirectly influences the treatment pro...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.